Vigliotti, Antonio, P.G. M.D. (UIA Investigator) — Moline, Illinois

Vigliotti, Antonio, P.G. M.D. (UIA Investigator) is a clinical research site located in Moline, Illinois, United States 61265.

Crixeo Clinical Trials Trust Score: 19/100 (FAILING). This profile has not yet been claimed by the site owner.

Vigliotti, Antonio, P.G. M.D. (UIA Investigator) has participated in 11 clinical trials with 2 currently active.

Therapeutic areas: Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Sponsors: ECOG-ACRIN Cancer Research Group, National Cancer Institute (NCI), Alliance for Clinical Trials in Oncology.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Moline

Browse all research sites in Illinois · View every site in Moline

Sponsor Feasibility Report

Trust Score: 19/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Vigliotti, Antonio, P.G. M.D. (UIA Investigator)?

Vigliotti, Antonio, P.G. M.D. (UIA Investigator) has a Crixeo Trust Score of 19/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Vigliotti, Antonio, P.G. M.D. (UIA Investigator) conducted?

Vigliotti, Antonio, P.G. M.D. (UIA Investigator) has 11 clinical trials on record, with 2 currently active. Their work covers Adenocarcinoma of the Rectum, Stage II Rectal Cancer, Stage III Rectal Cancer.

Is Vigliotti, Antonio, P.G. M.D. (UIA Investigator) accredited by Crixeo Clinical Trials?

Vigliotti, Antonio, P.G. M.D. (UIA Investigator) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Vigliotti, Antonio, P.G. M.D. (UIA Investigator)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.